Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor.
Eur J Med Chem
; 248: 115038, 2023 Feb 15.
Article
in En
| MEDLINE
| ID: mdl-36634458
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
TOR Serine-Threonine Kinases
/
Neoplasms
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Eur J Med Chem
Year:
2023
Type:
Article
Affiliation country:
Switzerland